Wockhardt is currently trading at Rs 1224.80, up by 29.55 points or 2.47% from its previous closing of Rs 1195.25 on the BSE.
The scrip opened at Rs 1228.90 and has touched a high and low of Rs 1240.00 and Rs 1215.00 respectively. So far 2935 shares were traded on the counter.
The BSE group 'T' stock of face value Rs 5 has touched a 52 week high of Rs 1437.85 on 11-Sep-2012 and a 52 week low of Rs 251.25 on 06-Jan-2012.
Last one week high and low of the scrip stood at Rs 1355.00 and Rs 1180.35 respectively. The current market cap of the company is Rs 13321.63 crore.
The promoters holding in the company stood at 73.64% while Institutions and Non-Institutions held 8.86% and 17.32% respectively.
The winding-up petition filed against Wockhardt by the Trustees to the Foreign Currency Convertible Bonds (FCCBs) before the Bombay high Court has been withdrawn.
Earlier in October 2009, the company had been hauled to Court after it defaulted on repaying its $110-million FCCB. The petition was filed by BNY Corporate Trustee Services (the Bank of New York Mellon) on behalf of bondholders, including Sun Pharma Global and QVT.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |